- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library
 |
 |
Estradiol (E2/E3) antibody and antigen (hapten, BSA/OVA conjugated)
Diagnostic anti-Estradiol (E2/E3) antibodies (anti-Estradiol, anti-E2/E3) and diagnostic hapten-carrier conjugates BSA-Estradiol (E2/E3), OVA-Estradiol (E2/E3), KLH-Estradiol (E2/E3) antigens for Hormone disorders E2/E3 detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to
Neurodegenerative diseases diagnostics
products collection
>>
Product information
| Catalog No. | Description | US $ Price (per mg) |
|---|---|---|
| GMP-SMT-E2-E3-Ag01 | BSA-Estradiol (E2/E3) | 756 |
| GMP-SMT-E2-E3-Ag02 | OVA-Estradiol (E2/E3) | 756 |
| GMP-SMT-E2-E3-Ab01 | Anti-human Estradiol (E2/E3) mouse monoclonal antibody (mAb) | 1953 |
| GMP-SMT-E2-E3-Ab02 | Anti-human Estradiol (E2/E3) human monoclonal antibody (mAb) | 1953 |
Size： 1mg | 10mg | 100mg
Product Description
| Cat No. of Products | GMP-SMT-E2-E3-Ag01 |
| Product Name | BSA-Estradiol (E2/E3) |
| Target/Biomarker | Estradiol (E2/E3) |
| Expression platform | Synthetic |
| Isotypes | NA |
| Bioactivity validation | Estradiol (E2/E3) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in E2/E3 level test of Hormone disorders (Fertility) and related syndrome evaluation. |
| Tag | NA |
| Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Estradiol (E2/E3) / OVA-Estradiol (E2/E3) is Synthetic. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Products | GMP-SMT-E2-E3-Ag02 |
| Product Name | OVA-Estradiol (E2/E3) |
| Target/Biomarker | Estradiol (E2/E3) |
| Expression platform | Synthetic |
| Isotypes | NA |
| Bioactivity validation | Estradiol (E2/E3) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in E2/E3 level test of Hormone disorders (Fertility) and related syndrome evaluation. |
| Tag | NA |
| Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Estradiol (E2/E3) / OVA-Estradiol (E2/E3) is Synthetic. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Products | GMP-SMT-E2-E3-Ab01 |
| Product Name | Anti-human Estradiol (E2/E3) mouse monoclonal antibody (mAb) |
| Target/Biomarker | Estradiol (E2/E3) |
| Expression platform | Hybridoma |
| Isotypes | Mouse IgG |
| Bioactivity validation | Estradiol (E2/E3) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in E2/E3 level test of Hormone disorders (Fertility) and related syndrome evaluation. |
| Tag | mFc |
| Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Estradiol (E2/E3) / OVA-Estradiol (E2/E3) is Synthetic. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. of Products | GMP-SMT-E2-E3-Ab02 |
| Product Name | Anti-human Estradiol (E2/E3) human monoclonal antibody (mAb) |
| Target/Biomarker | Estradiol (E2/E3) |
| Expression platform | Hybridoma |
| Isotypes | Mouse IgG |
| Bioactivity validation | Estradiol (E2/E3) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in E2/E3 level test of Hormone disorders (Fertility) and related syndrome evaluation. |
| Tag | mFc |
| Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Estradiol (E2/E3) / OVA-Estradiol (E2/E3) is Synthetic. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
| Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Estradiol plays a key role in the development of the female reproduction system, including the uterus, fallopian tubes, vagina, and breasts. Women have higher amounts of E2 during their reproductive years and almost none after menopause.Problem caused by high or low levels of E2 are Menstrual problems, ovarian tumors, gynecomastia, noncancerous growth of the glandular breast tissue in males, menopausal symptoms, breast cancer
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Facebook
LinkedIn
Twitter
Comments
No comments yet.